ACTRN12618000429257终止4 期
A multicentre, randomised, non-inferiority trial of chewing gum versus ondansetron to treat postoperative nausea and vomiting in female patients after breast or laparoscopic surgery (The Chewy Trial)
适应症
试验速览
- 阶段
- 4 期
- 状态
- 终止
- 入组人数
- 212
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 12 Years 至 o limit（—）
- 性别
- Female
入选标准
- •Female patients aged 12 years or older, weight 30 kg or more, preoperative Apfel score 2-4, presenting for breast or laparoscopic surgery under volatile-based, general anaesthesia.
排除标准
- •Patients having propofol-maintained general anaesthesia or inhalational induction without propofol co-induction, a contraindication to chewing gum, or any protocolised anti-emetic drug (prophylaxis, intervention or rescue), treatment with any of the study anti-emetic medications within 8 hours of induction of anaesthesia or planned post operative ventilation.
研究者
相似试验
尚未招募
不适用
What is the optimal treatment of a patent ductus arteriosus in preterm infants?preterm, newborn, patent ductus arteriosus, neonatologyte vroeg geborene, open ductus Botalli, neonatologieNL-OMON21314Radboud university medical centerNijmegen, The Netherlands564
进行中（未招募）
1 期
Study to investigate the optimal treatment of a patent ductus arteriosus (Botalli) in preterm newborn infants.Patent ductus arteriosus in the preterm infantEUCTR2017-001376-28-BERadboud University Medical Center564
已完成
不适用
Multi-center, randomized non-inferiority trial of early treatment versus expectative management of patent ductus arteriosus in preterm infants.Patent ductus arteriosusNL-OMON47250Radboud Universitair Medisch Centrum435
进行中（未招募）
1 期
Study to investigate the optimal treatment of a patent ductus arteriosus (Botalli) in preterm newborn infants.Patent ductus arteriosus in the preterm infantEUCTR2017-001376-28-NLRadboud University Medical Center564
已完成
3 期
A randomized, multicenter non-inferiority trial of 1-day versus 3-day dexamethasone in combination with palonosetron for prevention of nausea and vomiting induced by moderately emetogenic chemotherapycolorectal cancer, lung cancer, breast cancerJPRN-UMIN000009403Hokkaido University Hospital300